|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3 Suppl 49
|
|
pubmed:dateCreated |
2008-9-18
|
|
pubmed:abstractText |
To evaluate whether concomitant treatment with low-dose aspirin or other antiplatelet agents have an impact on the risk of severe ischemic complications and in the outcome of patients with giant cell arteritis (GCA).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0392-856X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
S57-62
|
|
pubmed:meshHeading |
pubmed-meshheading:18799055-Adrenal Cortex Hormones,
pubmed-meshheading:18799055-Aged,
pubmed-meshheading:18799055-Aged, 80 and over,
pubmed-meshheading:18799055-Case-Control Studies,
pubmed-meshheading:18799055-Cohort Studies,
pubmed-meshheading:18799055-Drug Therapy, Combination,
pubmed-meshheading:18799055-Female,
pubmed-meshheading:18799055-Follow-Up Studies,
pubmed-meshheading:18799055-Giant Cell Arteritis,
pubmed-meshheading:18799055-Humans,
pubmed-meshheading:18799055-Ischemia,
pubmed-meshheading:18799055-Male,
pubmed-meshheading:18799055-Middle Aged,
pubmed-meshheading:18799055-Platelet Aggregation Inhibitors,
pubmed-meshheading:18799055-Retrospective Studies
|
|
pubmed:articleTitle |
Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis.
|
|
pubmed:affiliation |
Department of Rheumatology, Hospital Universitario de Bellvitge-IDIBELL, Barcelona, Spain. 31577edd@comb.es
|
|
pubmed:publicationType |
Journal Article
|
